AAAAAA

   
Results: 1-18 |
Results: 18
PHASE-II STUDY OF IRINOTECAN AND ETOPOSIDE IN PATIENTS WITH METASTATIC NON-SMALL-CELL LUNG-CANCER
Authors: OSHITA F NODA K NISHIWAKI Y FUJITA A KURITA Y NAKABAYASHI T TOBISE K ABE S SUZUKI S HAYASHI I KAWAKAMI Y MATSUDA T TSUCHIYA S TAKAHASHI S TAMURA T SAIJO N
Citation: F. Oshita et al., PHASE-II STUDY OF IRINOTECAN AND ETOPOSIDE IN PATIENTS WITH METASTATIC NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 15(1), 1997, pp. 304-309
CHRONOPHARMACOLOGY OF ETOPOSIDE GIVEN BY LOW-DOSE PROLONGED INFUSION IN LUNG-CANCER PATIENTS
Authors: YAMAMOTO N TAMURA T OHE Y OSHITA F KASAI T KURATA T SHINKAI T EGUCHI K SAIJO N
Citation: N. Yamamoto et al., CHRONOPHARMACOLOGY OF ETOPOSIDE GIVEN BY LOW-DOSE PROLONGED INFUSION IN LUNG-CANCER PATIENTS, Anticancer research, 17(1B), 1997, pp. 669-672
SERUM LEVELS OF CYTOKINES IN PATIENTS WITH UNTREATED PRIMARY LUNG-CANCER
Authors: KATSUMATA N EGUCHI K FUKUDA M YAMAMOTO N OHE Y OSHITA F TAMURA T SHINKAI T SAIJO N
Citation: N. Katsumata et al., SERUM LEVELS OF CYTOKINES IN PATIENTS WITH UNTREATED PRIMARY LUNG-CANCER, Clinical cancer research, 2(3), 1996, pp. 553-559
RETROSPECTIVE ANALYSIS OF THE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER SHOWING POOR PERFORMANCE STATUS
Authors: SAKURAGI T OSHITA F NAGASHIMA S KASAI T KURATA T FUKUDA M YAMAMOTO N OHE Y TAMURA T EGUCHI K SHINKAI T SAIJO N
Citation: T. Sakuragi et al., RETROSPECTIVE ANALYSIS OF THE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER SHOWING POOR PERFORMANCE STATUS, Japanese Journal of Clinical Oncology, 26(3), 1996, pp. 128-133
CORRELATION OF GENE-SPECIFIC DAMAGE WITH CISPLATIN BETWEEN HUMAN ADENOCARCINOMA CELLS AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS ANALYZED BY POLYMERASE CHAIN REACTION-STOP ASSAY
Authors: OSHITA F ARIOKA H HEIKE Y SHIRAISHI J SAIJO N
Citation: F. Oshita et al., CORRELATION OF GENE-SPECIFIC DAMAGE WITH CISPLATIN BETWEEN HUMAN ADENOCARCINOMA CELLS AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS ANALYZED BY POLYMERASE CHAIN REACTION-STOP ASSAY, Japanese journal of cancer research, 86(2), 1995, pp. 233-238
PROSPECTIVE EVALUATION OF THE FEASIBILITY OF CISPLATIN-BASED CHEMOTHERAPY FOR ELDERLY LUNG-CANCER PATIENTS WITH NORMAL ORGAN FUNCTIONS
Authors: OSHITA F KURATA T KASAI T FUKUDA M YAMAMOTO N OHE Y TAMURA T EGUCHI K SHINKAI T SAIJO N
Citation: F. Oshita et al., PROSPECTIVE EVALUATION OF THE FEASIBILITY OF CISPLATIN-BASED CHEMOTHERAPY FOR ELDERLY LUNG-CANCER PATIENTS WITH NORMAL ORGAN FUNCTIONS, Japanese journal of cancer research, 86(12), 1995, pp. 1198-1202
INTENSIVE CHEMOTHERAPY WITH CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE,ETOPOSIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR FOR ADVANCED THYMOMA OR THYMIC CANCER - PRELIMINARY-RESULTS
Authors: OSHITA F KASAI T KURATA T FUKUDA M YAMAMOTO N OHE Y TAMURA T EGUCHI K SHINKAI T SAIJO N
Citation: F. Oshita et al., INTENSIVE CHEMOTHERAPY WITH CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE,ETOPOSIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR FOR ADVANCED THYMOMA OR THYMIC CANCER - PRELIMINARY-RESULTS, Japanese Journal of Clinical Oncology, 25(5), 1995, pp. 208-212
THE INFLUENCE OF AGING ON CISPLATIN PHARMACOKINETICS IN LUNG-CANCER PATIENTS WITH NORMAL ORGAN FUNCTION
Authors: YAMAMOTO N TAMURA T MAEDA M ANDO M SHINKAI T EGUCHI K OHE Y OSHITA F SHIRAISHI J KATSUMATA N SAIJO N
Citation: N. Yamamoto et al., THE INFLUENCE OF AGING ON CISPLATIN PHARMACOKINETICS IN LUNG-CANCER PATIENTS WITH NORMAL ORGAN FUNCTION, Cancer chemotherapy and pharmacology, 36(2), 1995, pp. 102-106
EFFICIENT SAMPLING STRATEGIES FOR FORECASTING PHARMACOKINETIC PARAMETERS OF IRINOTECAN (CPT-11) - IMPLICATION FOR AREA UNDER THE CONCENTRATION-TIME CURVE MONITORING
Authors: NAKASHIMA H LIEBERMAN R KARATO A ARIOKA H OHMATSU H NOMURA N SHIRAISHI J TAMURA T EGUCHI K SHINKAI T SASAKI Y YAMAMOTO N HUKUDA M OSHITA F OHE Y SAIJO N
Citation: H. Nakashima et al., EFFICIENT SAMPLING STRATEGIES FOR FORECASTING PHARMACOKINETIC PARAMETERS OF IRINOTECAN (CPT-11) - IMPLICATION FOR AREA UNDER THE CONCENTRATION-TIME CURVE MONITORING, Therapeutic drug monitoring, 17(3), 1995, pp. 221-229
CORRELATION OF THERAPEUTIC OUTCOME IN NONSMALL CELL LUNG-CANCER AND DNA-DAMAGE ASSAYED BY POLYMERASE CHAIN-REACTION IN LEUKOCYTES DAMAGED IN-VITRO
Authors: OSHITA F YAMAMOTO N FUKUDA M OHE Y TAMURA T EGUCHI K SHINKAI T SAIJO N
Citation: F. Oshita et al., CORRELATION OF THERAPEUTIC OUTCOME IN NONSMALL CELL LUNG-CANCER AND DNA-DAMAGE ASSAYED BY POLYMERASE CHAIN-REACTION IN LEUKOCYTES DAMAGED IN-VITRO, Cancer research, 55(11), 1995, pp. 2334-2337
CPT-11 - POPULATION PHARMACOKINETIC MODEL AND ESTIMATION OF PHARMACOKINETICS USING THE BAYESIAN METHOD IN PATIENTS WITH LUNG-CANCER
Authors: YAMAMOTO N TAMURA T KARATO A UENAKA K EGUCHI K SHINKAI T OHE Y OSHITA F ARIOKA H NAKASHIMA H SHIRAISHI J FUKUDA M HIGUCHI S SAIJO N
Citation: N. Yamamoto et al., CPT-11 - POPULATION PHARMACOKINETIC MODEL AND ESTIMATION OF PHARMACOKINETICS USING THE BAYESIAN METHOD IN PATIENTS WITH LUNG-CANCER, Japanese journal of cancer research, 85(9), 1994, pp. 972-977
RAPID POLYMERASE CHAIN-REACTION ASSAY TO DETECT VARIATION IN THE EXTENT OF GENE-SPECIFIC DAMAGE BETWEEN CISPLATIN-RESISTANT OR VP-16-RESISTANT AND SENSITIVE LUNG-CANCER CELL-LINES
Authors: OSHITA F SAIJO N
Citation: F. Oshita et N. Saijo, RAPID POLYMERASE CHAIN-REACTION ASSAY TO DETECT VARIATION IN THE EXTENT OF GENE-SPECIFIC DAMAGE BETWEEN CISPLATIN-RESISTANT OR VP-16-RESISTANT AND SENSITIVE LUNG-CANCER CELL-LINES, Japanese journal of cancer research, 85(7), 1994, pp. 669-673
PRELIMINARY EVALUATION OF THE NEW TUMOR-MARKER, CYFRA-21-1, IN LUNG-CANCER PATIENTS
Authors: KOGA H EGUCHI K SHINKAI T TAMURA T OHE Y OSHITA F SAIJO N KONDO H OKI K OKURA H
Citation: H. Koga et al., PRELIMINARY EVALUATION OF THE NEW TUMOR-MARKER, CYFRA-21-1, IN LUNG-CANCER PATIENTS, Japanese Journal of Clinical Oncology, 24(5), 1994, pp. 263-268
7-ETHYL-10-[4-(1-PIPERIDINO)-1-PIPERIDINO] CARBONYLOXY CAMPTOTHECIN -MECHANISM OF RESISTANCE AND CLINICAL-TRIALS
Authors: SAIJO N NISHIO K KUBOTA N KANZAWA F SHINKAI T KARATO A SASAKI Y EGUCHI K TAMURA T OHE Y OSHITA F NISHIO M
Citation: N. Saijo et al., 7-ETHYL-10-[4-(1-PIPERIDINO)-1-PIPERIDINO] CARBONYLOXY CAMPTOTHECIN -MECHANISM OF RESISTANCE AND CLINICAL-TRIALS, Cancer chemotherapy and pharmacology, 34, 1994, pp. 190000112-190000117
A RANDOMIZED PROSPECTIVE-STUDY OF IMIPENEM-CILASTATIN WITH OR WITHOUTAMIKACIN AS AN EMPIRICAL ANTIBIOTIC-TREATMENT FOR FEBRILE NEUTROPENICPATIENTS
Authors: KOJIMA A SHINKAI T SOEJIMA Y OKAMOTO H EGUCHI K SASAKI Y TAMURA T OSHITA F OHE Y SAIJO N
Citation: A. Kojima et al., A RANDOMIZED PROSPECTIVE-STUDY OF IMIPENEM-CILASTATIN WITH OR WITHOUTAMIKACIN AS AN EMPIRICAL ANTIBIOTIC-TREATMENT FOR FEBRILE NEUTROPENICPATIENTS, American journal of clinical oncology, 17(5), 1994, pp. 400-404
PHASE-I CLINICAL-TRIAL OF IRINOTECAN (CPT-11), PIPERIDINO)-1-PIPERIDINO]CARBONYLOXY-CAMPTOTHECIN, AND CISPLATIN IN COMBINATION WITH FIXED-DOSE OF VINDESINE IN ADVANCED NONSMALL CELL LUNG-CANCER
Authors: SHINKAI T ARIOKA H KUNIKANE H EGUCHI K SASAKI Y TAMURA T OHE Y OSHITA F NISHIO M KARATO A OKAMOTO H NAKASHIMA H OHMATSU H SHIRAISHI J NOMURA N SAIJO N
Citation: T. Shinkai et al., PHASE-I CLINICAL-TRIAL OF IRINOTECAN (CPT-11), PIPERIDINO)-1-PIPERIDINO]CARBONYLOXY-CAMPTOTHECIN, AND CISPLATIN IN COMBINATION WITH FIXED-DOSE OF VINDESINE IN ADVANCED NONSMALL CELL LUNG-CANCER, Cancer research, 54(10), 1994, pp. 2636-2642
GENE-SPECIFIC DAMAGE PRODUCED BY CISPLATIN, ORMAPLATIN AND UV-LIGHT IN HUMAN-CELLS AS ASSAYED BY THE POLYMERASE CHAIN-REACTION
Authors: OSHITA F EASTMAN A
Citation: F. Oshita et A. Eastman, GENE-SPECIFIC DAMAGE PRODUCED BY CISPLATIN, ORMAPLATIN AND UV-LIGHT IN HUMAN-CELLS AS ASSAYED BY THE POLYMERASE CHAIN-REACTION, Oncology research, 5(3), 1993, pp. 111-118
PHASE-I STUDY OF CPT-11 AND ETOPOSIDE IN PATIENTS WITH REFRACTORY SOLID TUMORS
Authors: KARATO A SASAKI Y SHINKAI T EGUCHI K TAMURA T OHE Y OSHITA F NISHIO M KUNIKANE H ARIOKA H OHMATSU H NAKASHIMA H SHIRAISHI J SAIJO N
Citation: A. Karato et al., PHASE-I STUDY OF CPT-11 AND ETOPOSIDE IN PATIENTS WITH REFRACTORY SOLID TUMORS, Journal of clinical oncology, 11(10), 1993, pp. 2030-2035
Risultati: 1-18 |